# Trade Mark Journal No.2025/038 19 September 2025

## WO0000001874167 (5,44)

Office of origin: Japan

Date of International Registration:10 July 2025
Date of designation in the UK: 10 July 2025

Class 5
  Pharmaceutical preparations; pharmaceutical preparations for treatment of erythropoietic protoporphyria and X-linked protoporphyria.
Class 44
  Providing medical information of erythropoietic protoporphyria and X-linked protoporphyria; providing medical information, consultancy and advisory services.

Mitsubishi Tanabe Pharma Corporation

Representative: YAMAO Norihito, AOYAMA & PARTNERS,, Osaka Umeda Twin Towers North,, 8-1, Kakuda-cho,, Kita-ku, Osaka-shi, Osaka 530-0017, JAPAN